Perakizumab
Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related) . Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis[1].
Product Specifications
CAS Number
89957-37-9
Product Name Alternative
RG4934
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/perakizumab.html
Purity
99.79
Solubility
H2O
Smiles
[Perakizumab]
Molecular Weight
(145.8 kDa)
References & Citations
[1][1] Dhavalkumar D Patel, et al. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii116-23.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
IL-17
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Yyj4726-1mgEcoli 1 mg (E. coli)
Recombinant Mycobacterium Smegmatis MSMEG_4149 Protein (aa 1-311)
Sign In for Pricing
View Details 
bs-0747R-PE-Cy5.5 100 µL
RANKL/CD254 Polyclonal Antibody, PE-Cy5.5 Conjugated
Sign In for Pricing
View Details